株探米国株
英語
エドガーで原本を確認する
6-K 1 tm2432044d1_6k.htm FORM 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December 2024

 

Commission File Number: 001-39591

 

 

 

iHuman Inc.

(Registrant’s Name)

 

 

 

Building A,
No. 1 Wangjing East Road,
Chaoyang District, Beijing 100102

People’s Republic of China

(Address of Principal Executive Offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x      Form 40-F ¨

 

 

 

 


 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press Release

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  iHuman Inc.
       
  By  : /s/ Vivien Weiwei Wang
  Name : Vivien Weiwei Wang
  Title : Director and Chief Financial Officer

 

Date: December 26, 2024

 

 

 

EX-99.1 2 tm2432044d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

 

BEIJING, China, Dec. 26, 2024 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.

 

Third Quarter 2024 Highlights

 

· Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.

· Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year.

· Operating income was RMB20.7 million (US$2.9 million), compared with RMB40.4 million in the same period last year.

· Net income was RMB25.1 million (US$3.6 million), compared with RMB51.9 million in the same period last year.

· Average total MAUs1 reached a record-high of 29.12 million, a year-over-year increase of 14.8%.

 

Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, “In the third quarter, we continued to see robust user demand for our products, driving average total MAUs to another record high of 29.12 million, representing a year-over-year increase of 14.8%. This growth underscores the effectiveness of our product strategy focused on innovation, overseas market expansion, and responsiveness to evolving market dynamics.

 

Domestically, we further strengthened our market leadership by enhancing our product portfolio with the launch of iHuman Chinese Reading. This new offering aims to cultivate an interest in Chinese reading, enhance literacy and verbal skills, and deepen children’s understanding of the Chinese culture. Developed by the same team behind our highly acclaimed iHuman Chinese app, iHuman Chinese Reading continues our proud tradition and commitment to excellent content and innovative design. The course features a leveled reading system that facilitates gradual progress in Chinese proficiency and offers a rich variety of content formats, such as ancient Chinese poems, interactive storybooks, and online study tours.

 

Building on our foundation, we expanded our content library by strengthening ties with influential industry players and leveraged our advanced technology to create richer and more immersive experiences for children. For instance, through our previously announced strategic partnership with Children’s Fun Publishing Co. Ltd., a leading children’s book publisher in China, we recently launched a new “Frozen” theme within iHuman Little Artists, where children can color their favorite Frozen characters and scenes, upload their artwork, and watch them come to life in a narrated storybook. This integration provides children with a creative way to experience the popular Frozen story while offering a highly interactive reading and drawing experience.

 

We also continued to roll out updates across other app products. For example, we added two new themes to iHuman Magic Thinking: “Sudoku” and “Thinking Logic.” “Sudoku” introduces children to Sudoku rules and mathematical concepts through short, animated stories and interactive challenges, and “Thinking Logic” engages them with a detective story series designed to sharpen judgment, analytical thinking, and problem-solving abilities.

 

 

1 “Average total MAUs” refers to the monthly average of the sum of the MAUs of each of the Company’s apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

 

1


 

On the international front, we enriched our portfolio with fresh content and features to boost user engagement and expand our global reach. Aha World received several updates, adding even more fun and adventure to its ever-expanding fantasy world. Children can now explore the “Love Animal Shelter,” where they can adopt, wash, and care for adorable virtual pets and enjoy an immersive and joyful pet ownership experience. For those captivated by the mystical, we introduced themes like “Magic School” and “Magic Street,” which take children on enchanting adventures and introduce magical shops filled with delightful surprises. These efforts have further boosted Aha World’s popularity. By the end of September, Aha World achieved over 502 million cumulative views across various social media platforms and attracted more than 1.4 million followers globally, reflecting its growing appeal among young users worldwide.

 

Looking ahead, we remain focused on enhancing our diverse portfolio across markets to better promote children’s holistic development while advancing our sustainable growth initiatives,” concluded Dr. Dai.

 

Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, “In the third quarter of 2024, we achieved our eleventh consecutive quarter of profitability, with net income reaching RMB25.1 million. This sustained financial strength enables us to continue expanding our impact across diverse channels and customer segments. For instance, our animation studio, Kunpeng, broadened its product lineup with the launch of a new animated series, “Rainbow Crew,” in October. The new series swiftly gained traction following its release, topping the charts for children’s shows on leading streaming platforms, including Tencent Video, iQIYI, and Youku.

 

Beyond consumer-facing products, we have also built a robust B2B model that currently supports nearly 10,000 kindergartens and institutions across China. Our tailored content resources and solutions empower these institutions with a comprehensive suite of diverse, ready-to-use products that effectively meet the developmental needs of young children, promoting the high-quality development of kindergartens and institutions. Recently, we have opened an experience center in Zhongshan, Guangdong Province, which combines education, entertainment, hands-on experience, and some unique features. Designed as a one-stop demonstration hub for institutional customers and vendors, the center is organized into six key areas—core content, specialty content, extended services, a multi-functional hall, indoor play spaces, and outdoor activity zones—showcasing our interactive products and innovative approach to supporting early childhood development in a kindergarten setting. This hands-on experience enables institutions to gain a deeper understanding of how our offerings can seamlessly integrate into their educational environments. Moving forward, we will leverage our solid financial foundation and innovative product ecosystem to deepen our impact in both the consumer and business segments, reinforcing our industry-leading position and creating value for our shareholders.”

 

Third Quarter 2024 Unaudited Financial Results

 

Revenues

 

Revenues were RMB239.4 million (US$34.1 million), a decrease of 8.4% from RMB261.5 million in the same period last year, primarily due to more conservative consumer spending.

 

Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user acquisition strategy and ongoing product innovation.

 

Cost of Revenues

 

Cost of revenues was RMB75.5 million (US$10.8 million), compared with RMB74.9 million in the same period last year.

 

Gross Profit and Gross Margin

 

Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year. Gross margin was 68.4%, compared with 71.4% in the same period last year. The slight decrease in gross margin was mainly due to our increased focus on the offline component in the integrated online-offline product strategy to enhance the attractiveness of the product.

 

Operating Expenses

 

Total operating expenses were RMB143.2 million (US$20.4 million), compared to RMB146.2 million in the same period last year.

 

2


 

Research and development expenses were RMB59.3 million (US$8.5 million), a decrease of 10.4% from RMB66.2 million in the same period last year, primarily due to savings in payroll related expenses.

 

Sales and marketing expenses were RMB60.9 million (US$8.7 million), an increase of 12.7% from RMB54.0 million in the same period last year, primarily due to increased strategic spending on promotional activities, brand enhancement, and overseas expansion.

 

General and administrative expenses were RMB23.0 million (US$3.3 million), a decrease of 11.8% from RMB26.1 million in the same period last year, primarily due to savings in payroll related expenses, share-based compensation expenses, as well as other administrative expenses.

 

Operating Income

 

Operating income was RMB20.7 million (US$2.9 million), compared with RMB40.4 million in the same period last year.

 

Net Income

 

Net income was RMB25.1 million (US$3.6 million), compared with RMB51.9 million in the same period last year.

 

Basic and diluted net income per ADS were RMB0.48 (US$0.07) and RMB0.47 (US$0.07), respectively, compared with RMB0.98 and RMB0.95 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

 

Deferred Revenue and Customer Advances

 

Deferred revenue and customer advances were RMB298.9 million (US$42.6 million) as of September 30, 2024, compared with RMB318.6 million as of December 31, 2023.

 

Cash, Cash Equivalents and Short-term Investments

 

Cash, cash equivalents and short-term investments were RMB1,168.6 million (US$166.5 million) as of September 30, 2024, compared with RMB1,213.8 million as of December 31, 2023.

 

Extension of Share Repurchase Program

 

Given its confidence in the Company’s business prospects, the board of directors (the “Board”) has authorized an extension of the Company’s existing share repurchase program, as authorized in December 2021 and extended to remain effective to the end of December 2024, by another twelve months through December 31, 2025. Pursuant to the extended share repurchase program, the Company’s proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.

 

Exchange Rate Information

 

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 30, 2024, which was RMB7.0176 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

 

3


 

Non-GAAP Financial Measures

 

iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman’s management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company’s current operating performance and prospects in the same manner as management does, if they so choose.

 

Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

 

Safe Harbor Statement

 

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about iHuman’s beliefs and expectations, are forward-looking statements. Among other things, the description of the management’s quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

 

About iHuman Inc.

 

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman’s unique, fun and interactive product offerings stimulate children’s natural curiosity and exploration. The Company’s comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children’s abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children’s behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

 

4


 

For more information about iHuman, please visit https://ir.ihuman.com/.

 

For investor and media enquiries, please contact:

 

iHuman Inc.

Mr. Justin Zhang

Investor Relations Director

Phone: +86 10 5780-6606

E-mail: ir@ihuman.com

 

Christensen

In China

Ms. Alice Li

Phone: +86-10-5900-1548

E-mail: alice.li@christensencomms.com

 

In the US

Ms. Linda Bergkamp

Phone: +1-480-614-3004

E-mail: linda.bergkamp@christensencomms.com

 

5


 

iHuman Inc.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)

except for number of shares, ADSs, per share and per ADS data)

 

    December 31,     September 30,     September 30,  
    2023     2024     2024  
      RMB       RMB       US$  
ASSETS                        
Current assets                        
Cash and cash equivalents     1,213,767       651,684       92,864  
Short-term investments     -       516,910       73,659  
Accounts receivable, net     60,832       66,376       9,459  
Inventories, net     16,518       16,882       2,406  
Amounts due from related parties     1,810       2,099       299  
Prepayments and other current assets     89,511       102,036       14,540  
Total current assets     1,382,438       1,355,987       193,227  
Non-current assets                        
Property and equipment, net     6,169       3,893       555  
Intangible assets, net     23,245       21,121       3,010  
Operating lease right-of-use assets     3,648       2,376       339  
Long-term investment     26,333       26,333       3,752  
Other non-current assets     8,662       10,937       1,556  
Total non-current assets     68,057       64,660       9,212  
Total assets     1,450,495       1,420,647       202,439  
                         
LIABILITIES                        
Current liabilities                        
Accounts payable     22,139       25,761       3,671  
Deferred revenue and customer advances     318,587       298,896       42,592  
Amounts due to related parties     4,428       20,719       2,952  
Accrued expenses and other current liabilities     143,677       116,382       16,584  
Dividend payable     -       30,139       4,295  
Current operating lease liabilities     1,927       1,683       240  
Total current liabilities     490,758       493,580       70,334  
Non-current liabilities                        
Non-current operating lease liabilities     1,933       735       105  
Total non-current liabilities     1,933       735       105  
Total liabilities     492,691       494,315       70,439  
SHAREHOLDERS’ EQUITY                        
Ordinary shares (par value of US$0.0001 per share, 700,000,000 Class A shares authorized as of December 31, 2023 and September 30, 2024; 125,122,382 Class A shares issued and 119,704,787 outstanding as of December 31, 2023; 125,122,382 Class A shares issued and 117,107,067 outstanding as of September 30, 2024; 200,000,000 Class B shares authorized, 144,000,000 Class B ordinary shares issued and outstanding as of December 31, 2023 and September 30, 2024; 100,000,000 shares (undesignated) authorized, nil shares (undesignated) issued and outstanding as of December 31, 2023 and September 30, 2024)     185       185       26  
Additional paid-in capital     1,088,628       996,089       141,942  
Treasury stock     (16,665 )     (23,579 )     (3,360 )
Statutory reserves     8,164       8,164       1,163  
Accumulated other comprehensive income     17,955       13,828       1,970  
Accumulated deficit     (140,463 )     (68,355 )     (9,741 )
Total shareholders’ equity     957,804       926,332       132,000  
Total liabilities and shareholders’ equity     1,450,495       1,420,647       202,439  

 

6


 

iHuman Inc.

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)

except for number of shares, ADSs, per share and per ADS data)

 

    For the three months ended     For the nine months ended  
    September 30,     June 30,     September 30,     September 30,     September 30,     September 30,     September 30,  
    2023     2024     2024     2024     2023     2024     2024  
    RMB     RMB     RMB     US$     RMB     RMB     US$  
Revenues     261,496       215,107       239,407       34,115       767,692       689,517       98,255  
Cost of revenues     (74,871 )     (63,372 )     (75,541 )     (10,765 )     (224,667 )     (205,805 )     (29,327 )
                                                         
Gross profit     186,625       151,735       163,866       23,350       543,025       483,712       68,928  
                                                         
Operating expenses                                                        
Research and development expenses     (66,168 )     (57,219 )     (59,307 )     (8,451 )     (191,253 )     (184,449 )     (26,284 )
Sales and marketing expenses     (53,994 )     (51,263 )     (60,863 )     (8,673 )     (134,993 )     (167,121 )     (23,815 )
General and administrative expenses     (26,070 )     (24,426 )     (22,998 )     (3,277 )     (78,787 )     (75,148 )     (10,709 )
Total operating expenses     (146,232 )     (132,908 )     (143,168 )     (20,401 )     (405,033 )     (426,718 )     (60,808 )
Operating income     40,393       18,827       20,698       2,949       137,992       56,994       8,120  
Other income, net     19,507       9,410       8,024       1,143       33,721       26,444       3,768  
Income before income taxes     59,900       28,237       28,722       4,092       171,713       83,438       11,888  
Income tax expenses     (7,984 )     (3,574 )     (3,579 )     (510 )     (24,077 )     (11,330 )     (1,615 )
Net income     51,916       24,663       25,143       3,582       147,636       72,108       10,273  
                                                         
Net income per ADS:                                                        
- Basic     0.98       0.47       0.48       0.07       2.79       1.37       0.20  
- Diluted     0.95       0.45       0.47       0.07       2.70       1.33       0.19  
                                                         
Weighted average number of ADSs:                                                        
- Basic     52,747,426       52,496,541       52,283,334       52,283,334       52,834,352       52,502,206       52,502,206  
- Diluted     54,772,536       54,295,419       54,011,420       54,011,420       54,753,124       54,332,011       54,332,011  
                                                         
Total share-based compensation expenses included in:                                                        
Cost of revenues     67       26       22       3       235       88       13  
Research and development expenses     1,160       348       225       32       2,940       1,030       147  
Sales and marketing expenses     147       45       39       6       585       130       19  
General and administrative expenses     1,105       392       329       47       3,557       1,022       146  

 

7


 

iHuman Inc.

 

UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

 

(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)

except for number of shares, ADSs, per share and per ADS data)

 

    For the three months ended     For the nine months ended  
    September 30,     June 30,     September 30,     September 30,     September 30,     September 30,     September 30,  
    2023     2024     2024     2024     2023     2024     2024  
    RMB     RMB     RMB     US$     RMB     RMB     US$  
Operating income     40,393       18,827       20,698       2,949       137,992       56,994       8,120  
Share-based compensation expenses     2,479       811       615       88       7,317       2,270       325  
Adjusted operating income     42,872       19,638       21,313       3,037       145,309       59,264       8,445  
                                                         
Net income     51,916       24,663       25,143       3,582       147,636       72,108       10,273  
Share-based compensation expenses     2,479       811       615       88       7,317       2,270       325  
Adjusted net income     54,395       25,474       25,758       3,670       154,953       74,378       10,598  
                                                         
Diluted net income per ADS     0.95       0.45       0.47       0.07       2.70       1.33       0.19  
Impact of non-GAAP adjustments     0.04       0.02       0.01       0.00       0.13       0.04       0.01  
Adjusted diluted net income per ADS     0.99       0.47       0.48       0.07       2.83       1.37       0.20  
                                                         
Weighted average number of ADSs – diluted     54,772,536       54,295,419       54,011,420       54,011,420       54,753,124       54,332,011       54,332,011  
Weighted average number of ADSs – adjusted     54,772,536       54,295,419       54,011,420       54,011,420       54,753,124       54,332,011       54,332,011  

 

8